Smoking Cessation for Tobacco-Related Cancer Prevention
Trial Summary
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on creating smoke-free homes to reduce secondhand smoke exposure.
What data supports the effectiveness of the treatment Smoke-Free Home Intervention for smoking cessation?
Is the Smoke-Free Home Intervention safe for humans?
The Smoke-Free Home Intervention has been studied in various settings, primarily focusing on promoting smoke-free environments to help reduce smoking. There is no specific safety data mentioned, but the intervention involves counseling and creating smoke-free spaces, which are generally considered safe activities.678910
How is the Smoke-Free Home Intervention treatment different from other smoking cessation treatments?
The Smoke-Free Home Intervention is unique because it focuses on creating a smoke-free environment at home, which can be more accessible and practical for individuals who cannot attend formal programs. This approach emphasizes the importance of a supportive home environment in quitting smoking, which is different from traditional methods that often rely on pharmacological aids or structured programs.211121314
What is the purpose of this trial?
This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.
Research Team
Michelle Kegler, DrPH, MPH
Principal Investigator
Emory University Hospital/Winship Cancer Institute
Eligibility Criteria
This trial is for individuals living in rural tribal communities who are interested in reducing secondhand smoke exposure from commercial tobacco in their homes. It aims to support smoking cessation and prevent tobacco-related cancer.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the smoke-free home program, consisting of mailed educational information and a coaching call
Follow-up
Participants are monitored for effectiveness of the smoke-free home intervention
Optional Extension
Participants in the control group may optionally receive the smoke-free home program after the 6 months follow-up
Treatment Details
Interventions
- Smoke-Free Home Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator